Balyasny Asset Management Portfolio holdings
AUM
$44B
1-Year Return
17.37%
This Quarter Return
-0.7%
1 Year Return
+17.37%
3 Year Return
+72.12%
5 Year Return
+152.69%
10 Year Return
+378.29%
AUM
$39.9B
AUM Growth
-$3.06B
(-7.1%)
Cap. Flow
-$2.28B
Cap. Flow
% of AUM
-5.71%
Top 10 Holdings %
Top 10 Hldgs %
11.13%
Holding
2,532
New
591
Increased
715
Reduced
610
Closed
508
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$484M |
| 2 |
Mastercard
MA
|
+$407M |
| 3 |
Charles Schwab
SCHW
|
+$400M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$287M |
| 5 |
Intuit
INTU
|
+$283M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$455M |
| 2 |
Coca-Cola
KO
|
+$423M |
| 3 |
Starbucks
SBUX
|
+$330M |
| 4 |
Salesforce
CRM
|
+$303M |
| 5 |
PNC Financial Services
PNC
|
+$274M |
Sector Composition
| 1 | Technology | 15.69% |
| 2 | Financials | 14.96% |
| 3 | Consumer Discretionary | 13.59% |
| 4 | Industrials | 10.73% |
| 5 | Healthcare | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Protalix BioTherapeutics
PLX
$135M
| $195K | ﹤0.01% |
+76,063
| New | +$195K |
|
1802
Sun Country Airlines
SNCY
$699M
| $192K | ﹤0.01% |
15,600
+3,300
| +27% | +$40.7K |
|
1803
Digital Turbine
APPS
$480M
| $191K | ﹤0.01% |
+70,290
| New | +$191K |
|
1804
Xeris Biopharma Holdings
XERS
$1.26B
| $189K | ﹤0.01% |
34,454
+17,301
| +101% | +$95K |
|
1805
Shore Bancshares
SHBI
$567M
| $189K | ﹤0.01% |
+13,960
| New | +$189K |
|
|
LOGC
1806
DELISTED
ContextLogic
LOGC
| $188K | ﹤0.01% |
26,983
+12,128
| +82% | +$84.7K |
|
1807
Hertz
HTZ
$1.82B
| $187K | ﹤0.01% |
47,465
+32,385
| +215% | +$128K |
|
1808
Annexon
ANNX
$252M
| $187K | ﹤0.01% |
+96,752
| New | +$187K |
|
1809
Western New England Bancorp
WNEB
$248M
| $185K | ﹤0.01% |
19,931
+8,206
| +70% | +$76.3K |
|
1810
Microvast
MVST
$913M
| $185K | ﹤0.01% |
+157,842
| New | +$185K |
|
1811
Xilio Therapeutics
XLO
$38.4M
| $184K | ﹤0.01% |
254,346
-88,884
| -26% | -$64.4K |
|
1812
Corvus Pharmaceuticals
CRVS
$442M
| $184K | ﹤0.01% |
57,827
+9,492
| +20% | +$30.2K |
|
1813
AbCellera Biologics
ABCL
$1.28B
| $181K | ﹤0.01% |
81,083
+67,562
| +500% | +$151K |
|
|
TECX
1814
Tectonic Therapeutic, Inc. Common Stock
TECX
$324M
| $181K | ﹤0.01% |
10,192
-236,808
| -96% | -$4.19M |
|
1815
FinWise Bancorp
FINW
$259M
| $180K | ﹤0.01% |
+10,289
| New | +$180K |
|
1816
Inhibikase Therapeutics
IKT
$115M
| $178K | ﹤0.01% |
+81,161
| New | +$178K |
|
1817
Vuzix
VUZI
$176M
| $176K | ﹤0.01% |
86,322
+50,923
| +144% | +$104K |
|
1818
Takeda Pharmaceutical
TAK
$48.3B
| $175K | ﹤0.01% |
11,773
-181,430
| -94% | -$2.7M |
|
1819
Hafnia
HAFN
$3.06B
| $175K | ﹤0.01% |
41,995
-15,990
| -28% | -$66.5K |
|
1820
Security National Financial
SNFCA
$231M
| $174K | ﹤0.01% |
+15,102
| New | +$174K |
|
|
BORR
1821
Borr Drilling
BORR
$884M
| $173K | ﹤0.01% |
+78,778
| New | +$173K |
|
1822
American Outdoor Brands
AOUT
$111M
| $171K | ﹤0.01% |
+14,077
| New | +$171K |
|
|
NEXN
1823
Nexxen International
NEXN
$606M
| $170K | ﹤0.01% |
+20,405
| New | +$170K |
|
1824
Blue Ridge Bankshares
BRBS
$380M
| $170K | ﹤0.01% |
52,091
+21,008
| +68% | +$68.5K |
|
1825
Agilon Health
AGL
$468M
| $170K | ﹤0.01% |
+39,166
| New | +$170K |
|